Work

P2.14-26 Outcomes in Patients with Compound Epidermal Growth Factor Receptor (EGFR) Mutations After Treatment with Tyrosine Kinase Inhibitors (TKIs)

Year: 2019

Type: article

Study design: Observational Study

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2019.08.1811

Authors: S. Breslin, J. Thompson, J. Morrissette, C. Ciunci, A. Singh, C. Aggarwal, R. Cohen, C. Langer, J. Bauml, M. Marmarelis

Institutions: Abramson Cancer Center, University of Pennsylvania

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2981497803

FWCI:

Cites:

Cited by:

Related to: 10